We studied the association of four polymorphisms in the ABCA1 gene (G1051A, G2706A, G2868A and –565C/T) with lipid profile and coronary artery disease.
Overall, 316 Tunisian patients underwent coronary angiography. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism analysis. Lipid and apolipoprotein concentrations were measured.
Only carriers of the G2706A allele were associated with a decreased risk of significant stenosis (odds ratio [OR] 0.66, 95 % confidence interval [CI] 0.22–0.92, p = 0.029), without pronounced effects on high-density lipoprotein (HDL) cholesterol. This protective effect was significant in smokers and diabetes. Carriers of the G1051A allele were associated only with increased concentrations of HDL cholesterol (p = 0.032). G2868A and –565C/T did not show any association with lipids or risk of significant stenosis. When ABCA1 polymorphisms were combined in haplotypes possessing G1051A, G2706A, G2868A and –565C/T, (AAGC) seemed to be most protective against significant stenosis (OR 0.5, 95 % CI 0.29–0.96, p = 0.048) whereas (GGAT) was probably the most atherogenic (OR 1.26, 95 % CI 1.03–1.56, p = 0.025).
Only the G2706A allele seems to be associated with a reduced risk of significant stenosis without important modification of HDL-cholesterol concentration, and appears to be more protective for smokers and diabetic patients. We found that (AAGC) seems to be a protective haplotype whereas (GGAT) has an atherogenic effect in a Tunisian population.